Makena
Generic name: Hydroxyprogesterone Injection
Drug class:
Progestins
Usage of Makena
Makena is a form of progestin, a manmade form of a female hormone called progesterone.
Makena is used to lower the risk of premature birth in a woman who has already had one premature baby. Makena will not stop premature labor that has already begun.
Makena is not for use in women who are pregnant with more than one baby (twins, triplets, etc).
Hydroxyprogesterone may also be used for purposes not listed in this medication guide.
Makena side effects
Get emergency medical help if you have signs of an allergic Reaction to Makena: hives, itching; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
Common Makena side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Makena
You should not be treated with Makena if you are allergic to hydroxyprogesterone or Castor oil, or if you have:
Makena is not approved for use by anyone younger than 16 years old.
Tell your doctor if you have ever had:
It is not known whether Makena will prevent any medical problems in a newborn baby. Talk to your doctor about your baby's individual risk.
Relate drugs
- Crinone
- Drospirenone
- Endometrin
- FIRST-Progesterone VGS 100
- FIRST-Progesterone VGS 200
- Hydroxyprogesterone
- Hydroxyprogesterone injection
- Makena
- Makena Auto-Injector
- Norgestrel
- Opill
- Ovrette
- Prochieve
- Progesterone
- Progesterone vaginal
- Prometrium
- Slynd
How to use Makena
Usual Adult Dose for Premature Labor:
To reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth: 250 mg intramuscularly once weekly. Begin treatment between 16 weeks, 0 days and 20 weeks, 6 days of gestation. Continue administration once weekly until week 37 (through 36 weeks, 6 days) of gestation or delivery, whichever occurs first.
Usual Pediatric Dose for Premature Labor:
To reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth: 16 years and older: 250 mg intramuscularly once weekly. Begin treatment between 16 weeks, 0 days and 20 weeks, 6 days of gestation. Continue administration once weekly until week 37 (through 36 weeks, 6 days) of gestation or delivery, whichever occurs first.
Warnings
You should not use Makena if you have: uncontrolled high blood pressure, unusual vaginal bleeding, liver disease or liver cancer, jaundice caused by your pregnancy, or if you have ever had circulation problems, a stroke or blood clot, or cancer of the breast, uterus/cervix, or vagina.
Your doctor will need to check your progress on a regular basis while you are using Makena. Do not miss any scheduled appointments. Every woman should remain under the care of a doctor during pregnancy.
Call your doctor at once if you have sudden numbness or weakness, confusion, problems with vision or speech, jaundice (yellowing of the skin or eyes), swelling in your hands or feet, pain or redness in one or both legs, or symptoms of depression (sleep problems, weakness, mood changes).
There are many other drugs that may interact with Makena. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products.
Do not start a new medication during pregnancy without telling your doctor.
What other drugs will affect Makena
Other drugs may interact with hydroxyprogesterone, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions